MedPath

Concomitant Tricuspid Repair in Patients With Left Heart Surgery

Not Applicable
Not yet recruiting
Conditions
Mitral Regurgitation
Cardiopulmonary Bypass
Tricuspid Regurgitation
Interventions
Device: Tricuspid repair
Registration Number
NCT05595187
Lead Sponsor
Nanjing Medical University
Brief Summary

Tricuspid regurgitation is common in patients with severe left heart diseases, such as degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform concomitant tricuspid-valve repair during left heart surgery in patients who have mild tricuspid regurgitation. To inform decision making, we will conduct a multicenter, randomized trial to assess the benefits and risks of tricuspid-valve repair at the time of left heart diseases in patients with mild tricuspid regurgitation who were undergoing surgery for left heart surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  1. Patients undergoing left heart valve surgery with mild tricuspid regurgitation;
  2. Patients aged 18-80 years;
  3. Agree to participate in this study and sign the informed consent form.
Exclusion Criteria
  1. Infective endocarditis within 3 months;
  2. Primary tricuspid regurgitation;
  3. Isolated tricuspid regurgitation
  4. Lactating women and suspected pregnant or pregnant women;
  5. Patients with mental disorders, drug and alcohol dependence;
  6. Those who participated in other clinical trials one month before the trial;
  7. Refusal to participate in this study without informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tricuspid repairTricuspid repairTricuspid repair techniques included suture placement and the type of prosthetic annuloplasty with specified the use of an approved rigid, incomplete, nonplanar, and undersized (ranging 26, 28, or 30, 32, 34 mm) ring.
Primary Outcome Measures
NameTimeMethod
A composite of adverse cardiovascular events2 years after surgery at follow-up

a composite of reoperation for tricuspid regurgitation, progression of tricuspid regurgitation from baseline by two grades or the presence of severe tricuspid regurgitation, or death.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The First Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, China

© Copyright 2025. All Rights Reserved by MedPath